Proteus®ONE solution comprises the latest technologies in proton therapy, making it the ideal platform for Research and Development purposes. Proteus®ONE solution is smaller, more affordable, easier to install and operate and is ultimately easier to finance than most common solutions. All these attributes make our proton therapy solutions accessible to more and more Healthcare Institutions worldwide. Proteus®ONE is equipped with Pencil Beam Scanning, a technology that offers high sub-millimeter precision treatment, which allows delivery of very high levels of conformity and dose uniformity, even in complex-shaped tumors, whilst at the same time sparing the surrounding healthy tissue.
* Proteus®ONE is the brand name of a new configuration of the Proteus® 235.
About IBA
Ad Statistics
Times Displayed: 61183
Times Visited: 1987 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry.
Headquartered in Belgium and employing about 1300 people worldwide, IBA has installed systems across the world. IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com.
Back to HCB News
